Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

21

Revenue 2017

41

Revenue 2017

Xarelto

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Xarelto was produced by Bayer and Johnson & Johnson.

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

FDA clears first generics of Pfizer/BMS’ anticoagulant Eliquis

Other directly-acting or ‘novel orally acting anticoagulants’ (NOACs) include Bayer/Johnson &Johnson's Xarelto (rivaroxaban) and Daiichi Sankyo's Lixiana/Savaysa – which like Eliquis are Factor Xa inhibitors – and Boehringer

The business case for patient engagement

The business case for patient engagement The results, as depicted in the chart, suggest that patients are equally likely to promote Xarelto and Eliquis, despite the latter earning more confidence. ... Are Lixiana users missing the confidence that Xarelto and Eliquis users have, and is this what

New faces at 11 London, ramarketing and MSL

New faces at 11 London, ramarketing and MSL He was part of the WPP team that won the global account for Xarelto, tasked with re- imagining Bayer’s biggest selling drug.

CHMP backs Lynparza in breast cancer, Dupixent in asthma

CHMP backs Lynparza in breast cancer, Dupixent in asthma It was rejected by the CHMP a year ago. Ondexxya is intended for use in patients taking Pfizer/Bristol-Myers Squibb's Eliquis (apixaban), Bayer/Johnson &Johnson's Xarelto (rivaroxaban) as

J&J earnings top expectations, but feels the squeeze in US

J&J earnings top expectations, but feels the squeeze in US Blockbuster Xarelto declines 14% due to US competition. Johnson &Johnson has released fourth quarter results showing better than expected overall growth, but also signs of a squeeze on some of its ... This includes cardiovascular blockbuster Xarelto,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics